Neurofeedback & qEEG Research Library
Neurofeedback studies can reach different conclusions depending on who rates symptoms, whether participants and assessors are blinded, and whether the study shows that participants actually learned to change the targeted signal.
Why this matters before purchasing treatment
A convincing percentage is not enough. Blinding, sham controls, demonstrated learning and real-world outcomes determine whether an apparent benefit is likely to be specific and meaningful.
Research Spotlight
Study design changes the conclusion
- Blinding reduces expectation bias
- Sham feedback tests specificity
- Learning must be demonstrated
- Daily-life outcomes matter
What the evidence suggests
Uncontrolled and non-blinded studies often report larger improvements. Sham-controlled research may find improvement in both real and placebo-feedback groups, showing that attention, expectation, structured practice and therapeutic contact can contribute to change.
What this could mean for you
Calgary Mind & Wellness Clinic interprets neurofeedback outcomes alongside symptoms and real-world functioning. A change in an EEG metric is not sufficient by itself; the person should also experience meaningful functional benefit.
A careful, individualized next step
Research informs—but does not replace—individual clinical judgment. We review symptoms, diagnosis, previous treatment, medications, contraindications, functional goals and the strength of evidence for the proposed protocol. A consultation does not guarantee that treatment will be recommended.
Ask better questions before committing
Our consultations use these same standards to discuss evidence, protocol fit, measurable goals and realistic expectations before any package is recommended.
Book a Consultation Explore the related Calgary service
Study citation
Methodological literature on sham-controlled neurofeedback trials and specific versus nonspecific effects. PMID: 40102367.
View the original record on PubMed
Educational information only. Findings from pooled research do not predict individual outcomes and may involve devices or protocols that differ from EXOMIND.